Predictive Oncology Inc (POAI)
1.435
-0.32
(-18.47%)
USD |
NASDAQ |
May 31, 16:00
1.43
0.00 (0.00%)
After-Hours: 20:00
Predictive Oncology Revenue (Quarterly): 0.4196M for March 31, 2024
Revenue (Quarterly) Chart
Historical Revenue (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2024 | 0.4196M |
| December 31, 2023 | 0.335M |
| September 30, 2023 | 0.7151M |
| June 30, 2023 | 0.4901M |
| March 31, 2023 | 0.2399M |
| December 31, 2022 | 0.3635M |
| September 30, 2022 | 0.4558M |
| June 30, 2022 | 0.3716M |
| March 31, 2022 | 0.3146M |
| December 31, 2021 | 0.4765M |
| September 30, 2021 | 0.3137M |
| June 30, 2021 | 0.3502M |
| March 31, 2021 | 0.2803M |
| December 31, 2020 | 0.2938M |
| September 30, 2020 | 0.4808M |
| June 30, 2020 | 0.1828M |
| March 31, 2020 | 0.2949M |
| December 31, 2019 | 0.3475M |
| September 30, 2019 | 0.5227M |
| June 30, 2019 | 0.2862M |
| March 31, 2019 | 0.2552M |
| December 31, 2018 | 0.3115M |
| September 30, 2018 | 0.3299M |
| June 30, 2018 | 0.3586M |
| March 31, 2018 | 0.4116M |
| Date | Value |
|---|---|
| December 31, 2017 | 0.2203M |
| September 30, 2017 | 0.1525M |
| June 30, 2017 | 0.1068M |
| March 31, 2017 | 0.1752M |
| December 31, 2016 | 0.1396M |
| September 30, 2016 | 0.1346M |
| June 30, 2016 | 0.0854M |
| March 31, 2016 | 0.0969M |
| December 31, 2015 | 0.1833M |
| September 30, 2015 | 0.0858M |
| June 30, 2015 | 0.234M |
| March 31, 2015 | 0.1513M |
| December 31, 2014 | 0.1658M |
| September 30, 2014 | 0.3973M |
| June 30, 2014 | 0.3183M |
| March 31, 2014 | 0.0702M |
| December 31, 2013 | 0.0817M |
| September 30, 2013 | 0.1078M |
| June 30, 2013 | 0.1509M |
| March 31, 2013 | 0.1277M |
| December 31, 2012 | 0.0896M |
| September 30, 2012 | 0.0516M |
| June 30, 2012 | 0.025M |
| March 31, 2012 | 0.0226M |
| December 31, 2011 | 0.074M |
Revenues Definition
Revenues measure the total amount of value that a company brings in during a certain period. This is also considered the "top-line" of the income statement. Revenues are used for all operating expenses as well as other line items which eventually lead to the net income for the company. Revenue is an extremely important metric when analyzing a company. A company with efficient margins is able to turn revenues into the most net income.
Revenue (Quarterly) Range, Past 5 Years
0.1828M
Minimum
Jun 2020
0.7151M
Maximum
Sep 2023
0.3767M
Average
0.3488M
Median
Revenue (Quarterly) Benchmarks
| icad Inc | 4.954M |
| Perspective Therapeutics Inc | -- |
| Semler Scientific Inc | 15.90M |
| Xtant Medical Holdings Inc | 27.87M |
| Asensus Surgical Inc | 1.123M |
Revenue (Quarterly) Related Metrics
| Net Income (Quarterly) | -4.219M |
| Total Expenses (Quarterly) | 4.656M |
| EPS Diluted (Quarterly) | -1.04 |
| Enterprise Value | 0.7277M |
| Gross Profit Margin (Quarterly) | 55.34% |
| Profit Margin (Quarterly) | -1.01K% |
| Earnings Yield | -254.4% |
| Normalized Earnings Yield | -251.73 |